U.S. Markets close in 2 hrs 28 mins

Tandem Diabetes Care, Inc. (TNDM)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
86.05-0.13 (-0.15%)
As of 1:31PM EDT. Market open.

Tandem Diabetes Care, Inc.

11075 Roselle Street
San Diego, CA 92121
United States
858 366 6900
http://www.tandemdiabetes.com

Sector(s)Healthcare
IndustryMedical Devices
Full Time Employees1,500

Key Executives

NameTitlePayExercisedYear Born
Mr. John F. SheridanPres, CEO & Director1.09M7.86M1955
Ms. Leigh A. VossellerExec. VP, CFO & Treasurer618.17k6.97M1973
Ms. Susan M. MorrisonExec. VP & Chief Admin. Officer616.87k6.88M1979
Mr. David B. BergerExec. VP, Chief Bus. Operations & Compliance Officer and Corp. Sec.617.65k4.1M1970
Mr. Brian B. HansenExec. VP & Chief Commercial Officer618.65k10.33M1968
Mr. Jim LealSr. VP of OperationsN/AN/AN/A
Mr. Manuel JaimeSr. VP of Technology & Digital HealthN/AN/AN/A
Mr. Ross SylviaVP of MarketingN/AN/AN/A
Ms. Elizabeth A. GasserExec. VP of Strategy & Corp. Devel.N/AN/A1976
Mr. Tom FoxSr. VP of HR & Organizational Devel.N/AN/AN/A
Amounts are as of December 31, 2020 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.

Description

Tandem Diabetes Care, Inc., a medical device company, designs, develops, and commercializes various products for people with insulin-dependent diabetes in the United States. The company's flagship product is the t:slim X2 insulin delivery system, a pump platform that comprises t:slim X2 pump, its 300-unit disposable insulin cartridge, and an infusion set. It also provides t:slim X2 insulin with Basal-IQ and control IQ technology; t:slim X2 with G5 Integration; and Tandem Device Updater, a tool that allows users to update their pump's software. In addition, the company offers t:connect, a web-based data management application, which provides a visual way to display diabetes therapy management data from the pump, continuous glucose monitoring, and supported blood glucose meters for users, their caregivers, and their healthcare providers; and Sugarmate, a mobile app for people with diabetes who use insulin. Its products in development include t:sport insulin delivery system; and connected (mobile) health offerings. Tandem Diabetes Care, Inc. has a development and commercialization agreement with Dexcom, Inc. The company was formerly known as Phluid Inc. and changed its name to Tandem Diabetes Care, Inc. in January 2008. Tandem Diabetes Care, Inc. was incorporated in 2006 and is headquartered in San Diego, California.

Corporate Governance

Tandem Diabetes Care, Inc.’s ISS Governance QualityScore as of April 30, 2021 is 10. The pillar scores are Audit: 2; Board: 8; Shareholder Rights: 8; Compensation: 10.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.